Mike Evers, Author at ORTHOWORLD

Aurora Spine Sales Decline on Product Line Cannibalization

Aurora Spine’s reliance on licensed third-party products has eroded sales of their internal products and reduced margins in 3Q19.

Nov 25, 2019

Entry Into Joint Replacement a Major Step in Globus Medical’s Evolution

Company Updates Competitive Landscape

In October 2019 we met with leaders from Globus Medical to discuss their acquisition of StelKast and entry into the joint replacement market.

Nov 22, 2019

Top 10 Takeaways from Orthopedics in 2019

Competitive Landscape Market Drivers

As we prepared our 2019 revenue projections for public companies, we took note of the major drivers in orthopedics of late. It was a busy year, with some surprising developments. After considering the stories behind companies’ 2019 performance, we offer these 10 takeaways, with specific examples.

Nov 22, 2019

Medtronic’s Surgical Synergy Strategy Accelerates Growth in Spine

Company Revenue The Numbers

Medtronic’s spine sales grew above market in FY 2Q20 on the strength of their Surgical Synergy strategy, combining capital equipment and implant hardware.

Nov 20, 2019

aap Gains Funding to Support Antibacterial Silver Coating Technology

Investments The Numbers

aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) to conceive and qualify a human clinical study to support market approval of its antibacterial silver coating technology.

Nov 19, 2019

Wright Medical Growth Downturn Continued in Lead Up to Stryker Deal

Company Revenue The Numbers

Before its acquisition by Stryker, Wright continued to face challenges in Cartiva distribution and increased competition in the foot and ankle market.

Nov 14, 2019